Prothena Corporation PLC (NASDAQ:PRTA)

33.10
Delayed Data
As of Feb 21
 +0.04 / +0.12%
Today’s Change
27.19
Today|||52-Week Range
70.00
-11.71%
Year-to-Date
FDA Accepts Acorda's NDA for Parkinson's Disease Candidate
Feb 21 / Zacks.com - Paid Partner Content
Will Prothena (PRTA) Disappoint Investors in Q4 Earnings?
Feb 09 / Zacks.com - Paid Partner Content
Prothena's (PRTA) Loss Narrows in Q4, Pipeline Progresses
Feb 15 / Zacks.com - Paid Partner Content